DNM1L and Parkinson disease: DRP1 is implicated in the pathogenesis of multiple neurodegenerative diseases such as ALS, AD, HD and PD [112–114], where dysregulation of DRP1 is associated with changes in mitochondrial morphology and decreased energy production in axons.